Hak E, Meijboom MJ, Buskens E. Modelling the health-economic impact of the next influenza pandemic in The Netherlands. Vaccine. 2006 Jun 9; [Epub ahead of print]
To optimally develop or adjust national contingency plans to respond to the next influenza pandemic, we developed a decision type model and estimated the total health burden and direct medical costs during the next possible influenza pandemic in the Netherlands on the basis of health care burden during a regular epidemic. Using an arithmetic decision tree-type model we took into account population characteristics, varying influenza attack rates, health care consumption according to the Dutch health care model and all-cause mortality. Actual direct medical cost estimates were based on the Dutch guidelines for pharmaco-economic evaluation. In the base-case scenario with no preventive measure available and an average influenza attack rate of 30%, 4,958,188 influenza infections, 1,552,687 GP consultations, 83,515 hospitalizations and 173,396 deaths will take place in The Netherlands. The burden is highest in adults aged 20 to 64 years. If minimizing the total mortality and sustaining highest net economic returns is the objective, this group needs to be targeted in interventions.
See Also:
Latest articles in those days:
- [preprint]Susceptibility of bovine respiratory and mammary epithelial cells to avian and mammalian derived clade 2.3.4.4b H5N1 highly pathogenic avian influenza viruses 18 hours ago
- Genetic Diversity of H10N3 Avian Influenza Virus Isolated from Anhui Province, China 18 hours ago
- Molecular origion of human infection with a novel avian influenza A H10N3 virus in China, 2021 19 hours ago
- Clade 2.3.4.4b but not historical clade 1 HA replicating RNA vaccine protects against bovine H5N1 challenge in mice 19 hours ago
- GGCX promotes Eurasian avian-like H1N1 swine influenza virus adaption to interspecies receptor binding 19 hours ago
[Go Top] [Close Window]